Most Recent

image: Chance and Necessity

Chance and Necessity

By | November 1, 2013

War and justice brought together two of the greatest minds of the 20th century, a scientist and a writer.

1 Comment

image: Contributors

Contributors

By | November 1, 2013

Meet some of the people featured in the November 2013 issue of The Scientist.

0 Comments

image: Penetrating the Brain

Penetrating the Brain

By | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

3 Comments

image: Drug-Resistant TB Underdiagnosed

Drug-Resistant TB Underdiagnosed

By | October 25, 2013

At least three-quarters of drug-resistant tuberculosis cases have not been detected, according to the World Health Organization.  

0 Comments

image: Evolving Pain Resistance

Evolving Pain Resistance

By | October 24, 2013

Grasshopper mice harbor mutations in a pain-transmitting sodium channel that allow them to prey on highly toxic bark scorpions.

2 Comments

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: A New Antibiotic?

A New Antibiotic?

By | October 16, 2013

Scientists show that peptide-conjugated phosphorodiamidate morpholino oligomers can effectively silence essential bacterial genes.

4 Comments

image: Fighting Viruses with RNAi

Fighting Viruses with RNAi

By | October 10, 2013

The long-debated issue of whether mammals can use RNA interference as an antiviral defense mechanism is finally put to rest.

0 Comments

image: Mislabeled Microbes Cause Two Retractions

Mislabeled Microbes Cause Two Retractions

By | October 10, 2013

Two papers on plant immunity have been retracted, and questions remain about others with similar results. 

9 Comments

image: Progress for First Malaria Vaccine

Progress for First Malaria Vaccine

By | October 8, 2013

Following successful clinical trials, GlaxoSmithKline says it will submit its malaria vaccine for European regulatory approval.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham